Lucid Diagnostics Inc.
NASDAQ:LUCDMedical - Devices
+$0.04 today
- Market cap
- $79.38M
- Beta
- 1.08
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$0.44
Volume 2.70M
Average 0.84M
LUCD Total Non-current Assets
All assets not expected to be converted to cash within one year.
Lucid Diagnostics Inc.NASDAQ: LUCD
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 48.3% from a year ago
Total non-current assets stood at $2.72M at the end of Q1 FY2026, down 48.3% from a year earlier and down 8.7% from the prior quarter. Over 3 fiscal years it compounded at -28.5% a year.
Context
- Total non-current assets amounted to 8.0% of total assets at the end of Q1 FY2026, down 8.1 pp from a year earlier.
- Total non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -48.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 2.98M USD
- Year-over-year change
- -46.5%
- 4-year CAGR
- +15.1%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.98M | -46.5% |
| FY2024 | 2024-12-31 | 5.57M | +7.1% |
| FY2023 | 2023-12-31 | 5.2M | -36.3% |
| FY2022 | 2022-12-31 | 8.15M | +380.7% |
| FY2021 | 2021-12-31 | 1.7M | — |
Total Non-current Assets vs competitors
How LUCD compares with its peers on the latest reported figures
- LUCD's Mar 2026 total non-current assets of $2.72M is the 9th highest of the 10 companies compared; the peer median is $13.14M.
- Its year-over-year change of -48.3% is the lowest of 10, against a peer median of -1.0%.
- Total non-current assets amounts to 8.0% of total assets for LUCD, versus a peer median of 21.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $251.67M | +400.6% | +79.0% | 85.7% | |
| Mar 2026 | $162.62M | +3382.9% | -77.8% | 89.8% | |
| Mar 2026 | $90.54M | -1.6% | +21.3% | 33.3% | |
| Mar 2026 | $19.9M | -7.8% | +24.6% | 38.6% | |
| Mar 2026 | $13.14M | -19.2% | -35.9% | 21.1% | |
| Mar 2026 | $8.23M | -1.0% | -1.7% | 13.1% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $8.05M | +38.6% | +25.0% | 2.7% |
| Mar 2026 | $4.31M | +44.4% | -18.5% | 5.0% | |
| Mar 2026 | $2.72M | -48.3% | -28.5% | 8.0% | |
IRDOpus Genetics, Inc. | Mar 2026 | $186K | -22.2% | +221.3% | 0.3% |
| Peer median (excluding LUCD) | $13.14M | -1.0% | +21.3% | 21.1% | |
Competitors are the stored peer set for LUCD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 53.66M | 22.47M | 18.9M | 22.36M | 34.71M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 200K | 17K | 45K | 405K | 643K |
| Inventory | 493K | 111K | 278K | 341K | 353K |
| Other Current Assets | 0 | 0 | 1.98M | 0 | 0 |
| Total Current Assets | 57.3M | 24.36M | 22.07M | 25.15M | 37.47M |
| Property, Plant & Equipment (Net) | 971K | 3.6M | 2.64M | 3.7M | 2.62M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 3.45M | 1.42M | 736K | 315K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 725K | 1.11M | 1.13M | 1.13M | 47K |
| Total Non-current Assets | 1.7M | 8.15M | 5.2M | 5.57M | 2.98M |
| Total Assets | 59M | 32.51M | 27.27M | 30.72M | 40.45M |
| Account Payables | 1.49M | 1.06M | 1.15M | 1.24M | 970K |
| Short-term Debt | 0 | 0 | 13.95M | 18.6M | 24M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 936K | 0 | 0 |
| Other Current Liabilities | 557K | 5.53M | 791K | 1.35M | 2.04M |
| Total Current Liabilities | 4.26M | 8.43M | 29.38M | 23.52M | 28.58M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 1.04M | 199K | 1.8M | 927K |
| Total Liabilities | 4.26M | 9.46M | 29.58M | 25.32M | 29.51M |
| Common Stock | 35K | 41K | 42K | 63K | 131K |
| Retained Earnings | (41.9M) | (98.08M) | (150.74M) | (203.77M) | (274.34M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 54.74M | 23.05M | (2.31M) | 5.39M | 10.94M |
| Total Debt | 0 | 2M | 15.26M | 21.25M | 25.82M |
| Net Debt | (53.66M) | (20.48M) | (3.64M) | (1.1M) | (8.89M) |
Lucid Diagnostics Inc.
NASDAQ:LUCD
Intrinsic Alpha fair value
Locked
Current Price
$0.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.